Intra-Cellular Therapies, Inc.·4

Feb 4, 5:01 PM ET

Narula Sanjeev 4

4 · Intra-Cellular Therapies, Inc. · Filed Feb 4, 2025

Insider Transaction Report

Form 4
Period: 2025-02-03
Narula Sanjeev
Executive Vice President & CFO
Transactions
  • Award

    Restricted Stock Units

    2025-02-03+22,72722,727 total
    Common Stock (22,727 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]On February 3, 2025, the reporting person was granted 22,727 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4